Efficacy and Safety of Ultra-Low-Dose Valganciclovir Chemoprophylaxis for Cytomegalovirus Infection in High-Risk Kidney Transplantation Patients. [electronic resource]
- Transplantation proceedings Oct 2019
- 2689-2692 p. digital
Publication Type: Journal Article
1873-2623
10.1016/j.transproceed.2019.04.078 doi
Adolescent Adult Antiviral Agents--administration & dosage Chemoprevention--methods Cytomegalovirus Infections--prevention & control Female Humans Kidney Transplantation--adverse effects Male Middle Aged Retrospective Studies Time Factors Treatment Outcome Valganciclovir--administration & dosage